Cerenia (Maropitant Citrate) Tablets for Dogs

Warnings

In puppies younger than 11 weeks of age, histological evidence of bone marrow hypocellularity was observed at higher frequency and greater severity in puppies treated with CERENIA compared to control puppies. In puppies 16 weeks and older, bone marrow hypocellularity was not observed.

Precautions

The safe use of CERENIA Tablets has not been evaluated in dogs or cats used for breeding, or in those who are pregnant or lactating.

Human Warnings

Not for use in humans. Keep out of the reach of children. In case of accidental ingestion, seek medical advice. Topical exposure may elicit localized allergic skin reactions in some individuals. Repeated or prolonged exposure may lead to skin sensitization. Wash hands with soap and water after administering drug. CERENIA is also an ocular irritant. In case of accidental eye exposure, flush with water for 15 minutes and seek medical attention.

Possible Side Effects

The following adverse events are based on post-approval adverse drug experience reporting. The following top 5 adverse events reported for dogs are listed in decreasing order of frequency: loss of apetite, depression/lethargy, hypersalivation, vomiting, and diarrhea.

Contact your veterinarian if you believe your pet is experiencing side effects.

Product Administration

Oral

Product Form

Tablet

Ingredients

Maropitant citrate

Storage

CERENIA Tablets should be stored at controlled room temperature 20°–25°C (68°–77°F) with excursions between 15°–30°C (59°–86°F).

Manufacturer

Zoetis

Prescribing Info/Brochures

• https://www.zoetisus.com/products/pages/cerenia/cerenia_tablets_and_injectable_marketing_package_insert.pdf?_ga=2.48285670.1581170424.1645854665-1921156053.1645854665